Biodesix, Inc. (BDSX)
14.17
-0.59
(-4.00%)
USD |
NASDAQ |
May 15, 16:00
14.14
-0.03
(-0.21%)
After-Hours: 20:00
Biodesix EPS Diluted (Quarterly) : -0.8071 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Interpace Biosciences, Inc. | 0.026 |
| GRAIL, Inc. | -2.293 |
| FONAR Corp. | 0.2441 |
| Thermo Fisher Scientific, Inc. | 4.426 |
| Innovative MedTech, Inc. | 0.0562 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.793M |
| Revenue (Quarterly) | 25.56M |
| Total Expenses (Quarterly) | 33.35M |
| Enterprise Value | 158.67M |
| Gross Profit Margin (Quarterly) | 83.55% |
| Profit Margin (Quarterly) | -30.50% |
| Earnings Yield | -28.42% |
| Normalized Earnings Yield | -28.46 |